Plus Therapeutics (PSTV) Gross Profit Growth (1y) (2012 - 2019)
Plus Therapeutics (PSTV) Gross Profit Growth (1y) (2012 - 2019) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Gross Profit Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
762,369.55 Bn |
762,369.51 Bn |
- |
- |
| 2 |
Belite Bio |
55,096.00 Bn |
55,096.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,755.80 Bn |
17,755.79 Bn |
- |
- |
| 4 |
Legend Biotech |
3,486.00 Bn |
3,485.71 Bn |
242.10 Mn |
75.94% |
| 5 |
Akari Therapeutics |
1,737.42 Bn |
1,737.41 Bn |
- |
- |
| 6 |
Evaxion A |
1,551.28 Bn |
1,551.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
227.32 Bn |
227.31 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
110.84 Bn |
103.59 Bn |
2.59 Bn |
7.76% |
| 9 |
Abivax |
91.71 Bn |
91.71 Bn |
- |
- |
| 10 |
Plus Therapeutics |
35.99 Mn |
20.87 Mn |
- |
- |
| Date | Value |
|---|
| Mar 31, 2019 |
287.50% |
| Dec 31, 2018 |
4,641.38% |
| Sep 30, 2018 |
1,250.00% |
| Jun 30, 2018 |
-88.55% |
| Mar 31, 2018 |
221.60% |
| Dec 31, 2017 |
-94.43% |
| Sep 30, 2017 |
-117.70% |
| Jun 30, 2017 |
-51.57% |
| Mar 31, 2017 |
-116.32% |
| Dec 31, 2016 |
-31.90% |
| Sep 30, 2016 |
-57.20% |
| Jun 30, 2016 |
70.13% |
| Mar 31, 2016 |
151.15% |
| Dec 31, 2015 |
-27.35% |
| Sep 30, 2015 |
45.86% |
| Jun 30, 2015 |
88.17% |
| Mar 31, 2015 |
-50.00% |
| Dec 31, 2014 |
-33.35% |
| Sep 30, 2014 |
-73.58% |
| Jun 30, 2014 |
-78.88% |
